health benefit

Research in Review
Advance Directives, QoL-Focused Care Needed for Cancer Patients With Delirium in the ED
08/03/2017
JCP Editors
Patients with advanced cancer who visit the emergency department (ED) with delirium have increased rates of hospitalizations and ICU admissions, along with decreased survival rates, according to a recent study...
Patients with advanced cancer who visit the emergency department (ED) with delirium have increased rates of hospitalizations and ICU admissions, along with decreased survival rates, according to a recent study...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
Dose Escalation of CML Treatment Improves Molecular Response Rates
08/02/2017
JCP Editors
Patients with chronic myeloid leukemia (CML) in the chronic phase may achieve molecular response with safe and effective treatment dose escalation, according to a recent study. ----- Related Content CML Mutations...
Patients with chronic myeloid leukemia (CML) in the chronic phase may achieve molecular response with safe and effective treatment dose escalation, according to a recent study. ----- Related Content CML Mutations...
...
08/02/2017
Journal of Clinical Pathways
Research in Review
CLL Long-Term Survival Likely to Improve With Novel Therapies
07/26/2017
JCP Editors
Novel agents are predicted to significantly improve lifetime overall survival (OS) and quality-adjusted life-years (QALYs) compared with traditional therapies for patients with chronic lymphocytic leukemia (CLL),...
Novel agents are predicted to significantly improve lifetime overall survival (OS) and quality-adjusted life-years (QALYs) compared with traditional therapies for patients with chronic lymphocytic leukemia (CLL),...
Novel...
07/26/2017
Journal of Clinical Pathways
Research in Review
Model Predicts Tumor Spread in Lung Cancer
07/17/2017
JCP Editors
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
...
07/17/2017
Journal of Clinical Pathways
Research in Review
Insulin Pump Therapy Inferior to Insulin Injections in Cost-Effectiveness
06/23/2017
JCP Editors
Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...
Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...
...
06/23/2017
Journal of Clinical Pathways
Research in Review
Blended Cognitive Behavior Therapy Decreases Fear of Cancer Recurrence
05/24/2017
JCP Editors
Survivors of cancer with fear of cancer recurrence may be effectively treated with a blended therapeutic approach involving face-to-face and online sessions, according to a study published in the Journal of Clinical...
Survivors of cancer with fear of cancer recurrence may be effectively treated with a blended therapeutic approach involving face-to-face and online sessions, according to a study published in the Journal of Clinical...
...
05/24/2017
Journal of Clinical Pathways
Research in Review
Trastuzumab Emtansine Improves OS in Patients With HER2+ Breast Cancer
05/19/2017
JCP Editors
Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer benefit from an estimated 7 additional months of survival if treated with trastuzumab emtansine rather than the physician’s choice...
Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer benefit from an estimated 7 additional months of survival if treated with trastuzumab emtansine rather than the physician’s choice...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
New Biomarker Helps Predict PFS in Patients With Type of NSCLC
05/05/2017
JCP Editors
Patients with ALK-rearranged non-small cell lung cancer (NSCLC) who are treated with crizotinib may experience increased progression-free survival (PFS) with a decrease in a type of circulating tumor cells, according...
Patients with ALK-rearranged non-small cell lung cancer (NSCLC) who are treated with crizotinib may experience increased progression-free survival (PFS) with a decrease in a type of circulating tumor cells, according...
...
05/05/2017
Journal of Clinical Pathways
Research in Review
MRI Results After DCIS Biopsy Unreliable, Leads to Overtreatment
05/04/2017
JCP Editors
MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...
MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...
MRI...
05/04/2017
Journal of Clinical Pathways
Research in Review
Removing Metastases Improves Survival for Patients With Kidney Cancer
04/28/2017
JCP Editors
Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...
Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...
...
04/28/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use